Oncology

Latest News

FDA Approved | Image credit: chrisdorney – stock.adobe.com
Teliso-V Approved to Treat Advanced NSCLC With High c-Met Protein Overexpression

May 14th 2025

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung cancer (NSCLC) with high c-Met overexpression, offering new hope.

While CTCs were identified regardless of disease stage, the current study identified large variations in the presence of CTCs between nonmetastatic and metastatic disease | Image Credit: Innovative Creation - stock.adobe.com
Flow Cytometry Can Reliably Identify CTC in Melanoma

May 14th 2025

Jack & Sheryl Morris Cancer Center | Image credit: RWJBarnabas Health
New Jersey’s First Freestanding Cancer Hospital Opens in New Brunswick

May 14th 2025

At 3 months, hospitalizations among patients enrolled in RSM were 19% lower vs historical controls. | Image Credit: Nuttapong punna - stock.adobe.com
Remote Symptom Monitoring Linked to Reduced Hospitalization Risk for Patients With Cancer

May 14th 2025

Offline data augmentation can significantly enhance deep learning techniques, improving classification performance compared to models trained solely on original clinician skin images. | Image Credit: Alexander - stock.adobe.com
Optimized Deep Learning Model Classifies Smartphone Images of Malignant Skin Lesions

May 12th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Lessons From the Field: How Practices Are Succeeding Under OCM
September 18th 2019

Lessons From the Field: How Practices Are Succeeding Under OCM

Jaime Rosenberg
As rising drug costs continue to take up a larger portion of the total cost of care, practices in the Oncology Care Model find themselves in control of a shrinking portion of total costs, according to anecdotes from an academic medical center and a community-based practice during the National Comprehensive Cancer Network’s Policy Summit held September 12 in Washington, DC.
Lani Alison Discusses How the OCM Allowed for Better Integration of Palliative Care
September 15th 2019

Lani Alison Discusses How the OCM Allowed for Better Integration of Palliative Care

Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains how the implementation of the Oncology Care Model (OCM) allowed practices to better integrate palliative care.
Dr Iuliana Shapira Offers Examples of How Innovation Can Transform Cancer Care Delivery
September 10th 2019

Dr Iuliana Shapira Offers Examples of How Innovation Can Transform Cancer Care Delivery

Innovation that transform cancer care delivery have to be multi-level, explained Iuliana Shapira, MD, chief medical officer, Regional Cancer Care Associates.
Mike Fazio: Practices Are Happier With PP4 Results in the OCM
September 7th 2019

Mike Fazio: Practices Are Happier With PP4 Results in the OCM

There are less surprises in the results for performance period 4 of the Oncology Care Model, and practices seem to be mostly happier with how they’ve done, said Mike Fazio, senior vice president of client services, Archway Health.
Lani Alison Outlines Questions Patients Have About Care Pathways, Treatment Guidelines
September 5th 2019

Lani Alison Outlines Questions Patients Have About Care Pathways, Treatment Guidelines

Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains the questions that patients have about oncology care pathways and treatment guidelines.
Dr Shalom Kalnicki Discusses Bringing Value-Based Care to Radiation Oncology
September 1st 2019

Dr Shalom Kalnicki Discusses Bringing Value-Based Care to Radiation Oncology

The cost of radiation oncology services has typically been a small part of the Medicare and Medicaid budget, but with more patients having complex radiation treatments, it is becoming more important to have alternative payment models in the space, said Shalom Kalnicki, MD, FASTRO, FACRO, professor and chairman, radiation oncology, Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine.
Incidences and Burden of Childhood Cancer Continue to Increase
August 31st 2019

Incidences and Burden of Childhood Cancer Continue to Increase

Alison Rodriguez
Unlike cancers common in adults, childhood cancers are unlikely to be prevented by screening.
Dr Iuliana Shapira on Managing High Costs of Immuno-Oncology Drugs in Value-Based Care
August 28th 2019

Dr Iuliana Shapira on Managing High Costs of Immuno-Oncology Drugs in Value-Based Care

Iuliana Shapira, MD, chief medical officer, Regional Cancer Care Associates (RCCA), discusses how RCCA is managing the higher costs of immuno-oncology drugs in value-based care.
Childhood Cancer Survivors Have a Heightened Risk of Heart Disease, Study Shows
August 26th 2019

Childhood Cancer Survivors Have a Heightened Risk of Heart Disease, Study Shows

Matthew Gavidia
Cancer treatment raises the risk of heart disease in childhood cancer survivors, as does diabetes and hypertension.
Dr Ginah Nightingale: Challenges of Treating Seniors With Cancer With Combination Therapies
August 25th 2019

Dr Ginah Nightingale: Challenges of Treating Seniors With Cancer With Combination Therapies

When seniors with cancer are being treated with combination therapies, providers need to keep in mind more than just the complex regimens they’re administering, said Ginah Nightingale, PharmD, associate professor of pharmacy practice at Jefferson College of Pharmacy.
Phase 1 Pancreatic Cancer Trial Identifies Effective Combination Treatment
August 23rd 2019

Phase 1 Pancreatic Cancer Trial Identifies Effective Combination Treatment

Alison Rodriguez
Finding a cure for pancreatic cancer, which is among the deadliest cancers, will require both systemic therapy and local therapy, researchers said.
Research Reveals a Lack of Racial Diversity in Clinical Trials for Cancer Drugs
August 21st 2019

Research Reveals a Lack of Racial Diversity in Clinical Trials for Cancer Drugs

Matthew Gavidia
A new study shows a lack of racial and ethnic diversity in clinical trials for cancer drugs, highlighting issues currently being addressed by the FDA.
Lani Alison: How Providers Discuss the OCM With Patients
August 18th 2019

Lani Alison: How Providers Discuss the OCM With Patients

Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, discusses how providers discuss the Oncology Care Model (OCM) with patients and the questions they ask about it.
Site Logo
August 17th 2019

AJMCtv Interviews

AJMC Staff
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.
Site Logo
August 17th 2019

Medical World News: Policy, Clinical, and Managed Care Updates

Alison Rodriguez Laura Joszt, MA Mary Caffrey Jaime Rosenberg
Chronic pain, obesity and cancer, multiple myeloma patterns, pancreatic cancer screening updates, and more.
Site Logo
August 17th 2019

Conference Coverage: NCCN Policy Summit

Jaime Rosenberg
Coverage from the National Comprehensive Cancer Network Policy Summit held June 27, 2019, in Washington, DC.
Site Logo
August 17th 2019

From the Editor-in-Chief: Within Ourselves

Joseph Alvarnas, MD
The fault, dear Brutus, is not in our stars, but in ourselves... Julius Caesar (I, ii, 140-141)
Inherited Gene Mutation Found to Raise Pancreatic Cancer Risk, Among Other Malignancies
August 15th 2019

Inherited Gene Mutation Found to Raise Pancreatic Cancer Risk, Among Other Malignancies

Matthew Gavidia
Scientists uncovered a rare, inherited gene mutation, known as RABL3, that raises the risk of pancreatic and other cancers.
Site Logo
August 14th 2019

Genetic Testing Can Reduce Suffering and Save Lives

Lauren Corduck
The founder of Oneinforty discusses the importance of identifying populations at high risk of hereditary cancers, as well as the need for education, testing, and other steps to prevent cancer.
Site Logo
August 14th 2019

How Data, AI Are Unlocking Secrets to Better, More Efficient Cancer Care

Allison Inserro
The Institute for Value-Based Medicine®, an initiative of The American Journal of Managed Care®, traveled to Teaneck, New Jersey, for presentations in partnership with Regional Cancer Care Associates.
Site Logo
August 14th 2019

Florida Cancer Specialists, Cigna Expand Collaboration to All Cancer Types

AJMC Staff
A 28% reduction in hospital admissions leads to a broader agreement, the physicians' group and payer say.
Site Logo
August 14th 2019

Jim Allison: Breakthrough Traces the Unexpected Creative Paths of a Scientist and Immuno-Oncology

Mary Caffrey
A review of the documentary on the life of James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center, co-winner of the 2018 Nobel Prize in Physiology or Medicine.
How Are Oncology Practices Communicating Value-Based Care to Employers and Patients?
August 14th 2019

How Are Oncology Practices Communicating Value-Based Care to Employers and Patients?

On this episode of Managed Care Cast, we’re bringing you a portion of a panel discussion about the Oncology Care Model, held in July 2019 during a meeting of The Institute for Value-Based Medicine® (IVBM), an initiative of The American Journal of Managed Care®. At IVBM events, we gather thought leaders to share best practices across medicine, pharmacy, and management in regional locations around the country. This podcast is taken from our meeting focusing on Innovation and Quality in Oncology Care.
Study Finds Familial Risks of Second Primary Cancers for Patients With Malignant Melanoma
August 11th 2019

Study Finds Familial Risks of Second Primary Cancers for Patients With Malignant Melanoma

Alison Rodriguez
As survival rates for malignant melanoma increase, so does the likelihood that some patients will develop second primary cancers.
Podcast: This Week in Managed Care—Pancreatic Cancer Screening and Other Health News
August 11th 2019

Podcast: This Week in Managed Care—Pancreatic Cancer Screening and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
OneOncology Has Begun Administering Bevacizumab, Trastuzumab Biosimilars
August 8th 2019

OneOncology Has Begun Administering Bevacizumab, Trastuzumab Biosimilars

Jaime Rosenberg
Weeks after the first 2 anticancer biosimilars entered the US market, OneOncology announced that its partner practices have already started administering the drugs.
Lani Alison on How Innovation Is Being Used to Improve Quality Metrics in Oncology
August 6th 2019

Lani Alison on How Innovation Is Being Used to Improve Quality Metrics in Oncology

Innovation is being used to improve quality metrics in oncology care at the patient forefront and in data, explained Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates.
One Dose of HPV Vaccine Effective in Preventing Cervical Cancer Compared With Multiple Doses, Researchers Say
August 5th 2019

One Dose of HPV Vaccine Effective in Preventing Cervical Cancer Compared With Multiple Doses, Researchers Say

Matthew Gavidia
A single-dose human papillomavirus (HPV) vaccination strategy could be effective in less developed countries, where cost is in consideration.
How Are States Dealing With Challenges Facing Patients With Cancer?
July 31st 2019

How Are States Dealing With Challenges Facing Patients With Cancer?

Jaime Rosenberg
High costs of care, particularly for prescription drugs, dominated a discussion of cancer care at the state level during the June 27, 2019, National Comprehensive Cancer Network Policy Summit in Washington, DC.
Hospitals Affiliated With Top-Ranked Cancer Hospitals Have Modest Safety Advantage for Cancer Surgery
July 28th 2019

Hospitals Affiliated With Top-Ranked Cancer Hospitals Have Modest Safety Advantage for Cancer Surgery

Alison Rodriguez
The study found that the advantage was due to factors that affect hospital safety, which were present before affiliation and increased afterward.
<1
...
222324252627282930
...
185>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo